Assertion: ace inhibitor | /r/HasProperty | aceis
Facets:
Source sentences:
text: The role of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin-receptor blockers (ARBs) in COVID-19 disease susceptibility, severity, and treatment is unclear.
text: Although the preoperative use of an angiotensin-converting enzyme inhibitor (ACEI) can be expected in as many as 13% of these surgeries,3 the optimal preoperative ACEI management strategy for patients undergoing NCNV surgeries is poorly understood.
text: While only one trial randomized drug classes, i.e. AASK, the others randomized BP levels and also used ACE inhibitors (ACEIs) because angiotensin receptor blockers (ARBs) were not available when they were done.
text: ACE inhibitors (ACEI) and angiotensin receptor blockers (ARB) can lead to an increase in the expression of ACE2.
text: According to the National Health and Nutrition Examination Survey, from 2011 to 2012, an estimated 12% of adults in the US used an angiotensin-converting enzyme inhibitor (ACE-I) and 5.8% used an angiotensin receptor blocker (ARB).1
text: Concerns exist that angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin-receptor blockers (ARBs) increase susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, the viral agent that causes the disease COVID-19) and the likelihood of severe COVID-19 illness (1).
text: Physicians, healthcare professionals, researchers, and patients are actively debating the potential influence of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in patients during the COVID-19 outbreak.
text: Physicians, healthcare professionals, researchers, and patients are actively debating the potential influence of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in patients during the COVID-19 outbreak.
text: Background Trimethoprim therapy can cause hyperkalemia and is often coprescribed with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs).
text: Emerging concerns that common antihypertensive treatment approaches with angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) – jointly known as renin-angiotensin-aldosterone system (RAAS)
text: individuals with CV risk factors are often treated with angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs).
text: “Patients with cardiovascular disease diagnosed with novel coronavirus (COVID-19) are urged to continue taking their angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) medications as prescribed, according to a statement jointly published by the American Heart Association (AHA), the Heart Failure Society of America (HFSA), and the American College of Cardiology (ACC).
text: Researchers in India have conducted a meta-analysis investigating the effects of using angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) on outcomes among patients with COVID-19.
text: Synonyms: ACE inhibitors, ACEIs, ACEs